162 related articles for article (PubMed ID: 15057265)
21. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
22. Deficiency of oncoretrovirally transduced hematopoietic stem cells and correction through ex vivo expansion.
Bryder D; Björgvinsdóttir H; Sasaki Y; Jacobsen SE
J Gene Med; 2005 Feb; 7(2):137-44. PubMed ID: 15538726
[TBL] [Abstract][Full Text] [Related]
23. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
[TBL] [Abstract][Full Text] [Related]
24. OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 h.
Treschow A; Unger C; Aints A; Felldin U; Aschan J; Dilber MS
Gene Ther; 2007 Nov; 14(22):1564-72. PubMed ID: 17898799
[TBL] [Abstract][Full Text] [Related]
25. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
[TBL] [Abstract][Full Text] [Related]
26. Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression.
Schambach A; Bohne J; Baum C; Hermann FG; Egerer L; von Laer D; Giroglou T
Gene Ther; 2006 Apr; 13(7):641-5. PubMed ID: 16355114
[TBL] [Abstract][Full Text] [Related]
27. Retroviral bicistronic vectors.
Pfützner W
Drug News Perspect; 2008 Nov; 21(9):473-80. PubMed ID: 19180265
[TBL] [Abstract][Full Text] [Related]
28. Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus.
Schambach A; Schiedlmeier B; Kühlcke K; Verstegen M; Margison GP; Li Z; Kamino K; Bohne J; Alexandrov A; Hermann FG; von Laer D; Baum C
Gene Ther; 2006 Jul; 13(13):1037-47. PubMed ID: 16541120
[TBL] [Abstract][Full Text] [Related]
29. Viral or non-viral angiogenesis gene transfer-New answers to old questions.
Nikol S
Cardiovasc Res; 2007 Feb; 73(3):443-5. PubMed ID: 17196566
[No Abstract] [Full Text] [Related]
30. Stable, long-term label opens doors for gene therapy.
Lundberg C
Gene Ther; 2005 Feb; 12(3):195. PubMed ID: 15578042
[No Abstract] [Full Text] [Related]
31. In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells.
Dumey N; Mongiat-Artus P; Devauchelle P; Lesourd A; Cotard JP; Le Duc A; Marty M; Cussenot O; Cohen-Haguenauer O
Eur Urol; 2005 Feb; 47(2):257-63. PubMed ID: 15661423
[TBL] [Abstract][Full Text] [Related]
32. Transgenic mice produced by retroviral transduction of male germ line stem cells in vivo.
Kanatsu-Shinohara M; Toyokuni S; Shinohara T
Biol Reprod; 2004 Oct; 71(4):1202-7. PubMed ID: 15189822
[TBL] [Abstract][Full Text] [Related]
33. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
Ghani K; Cottin S; Kamen A; Caruso M
Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
[TBL] [Abstract][Full Text] [Related]
34. Optimization of equine infectious anemia derived vectors for hematopoietic cell lineage gene transfer.
O'Rourke JP; Olsen JC; Bunnell BA
Gene Ther; 2005 Jan; 12(1):22-9. PubMed ID: 15550928
[TBL] [Abstract][Full Text] [Related]
35. Cre-loxP adenovirus-mediated foreign gene expression in skin-equivalent keratinocytes.
Hanakawa Y; Shirakata Y; Nagai H; Yahata Y; Tokumaru S; Yamasaki K; Tohyama M; Sayama K; Hashimoto K
Br J Dermatol; 2005 Jun; 152(6):1391-2. PubMed ID: 15949030
[No Abstract] [Full Text] [Related]
36. Widespread and highly persistent gene transfer to the CNS by retrovirus vector in utero: implication for gene therapy to Krabbe disease.
Shen JS; Meng XL; Yokoo T; Sakurai K; Watabe K; Ohashi T; Eto Y
J Gene Med; 2005 May; 7(5):540-51. PubMed ID: 15685691
[TBL] [Abstract][Full Text] [Related]
37. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
38. Transduction of human embryonic stem cells by ecotropic retroviral vectors.
Koch P; Siemen H; Biegler A; Itskovitz-Eldor J; Brüstle O
Nucleic Acids Res; 2006; 34(18):e120. PubMed ID: 16998181
[TBL] [Abstract][Full Text] [Related]
39. From leading role to the backstage: mesenchymal stem cells as packaging cell lines for in situ production of viral vectors.
Silva FH; Nardi NB
Med Hypotheses; 2006; 67(4):922-5. PubMed ID: 16737782
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy progress and prospects: cystic fibrosis.
Griesenbach U; Geddes DM; Alton EW
Gene Ther; 2006 Jul; 13(14):1061-7. PubMed ID: 16819538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
